Zhang Jing, Tang Hua, Liu Zefa, Chen Baoan
Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing.
Department of Hematology, People's Hospital of Xinghua City, Xinghua City, Jiangsu Province, People's Republic of China.
Int J Nanomedicine. 2017 Nov 28;12:8483-8493. doi: 10.2147/IJN.S148359. eCollection 2017.
Chemotherapy is still one of the main cancer therapy treatments, but the curative effect of chemotherapy is relatively low, as such the development of a new cancer treatment is highly desirable. The gradual maturation of nanotechnology provides an innovative perspective not only for cancer therapy but also for many other applications. There are a diverse variety of nanoparticles available, and choosing the appropriate carriers according to the demand is the key issue. The performance of nanoparticles is affected by many parameters, mainly size, shape, surface charge, and toxicity. Using nanoparticles as the carriers to realize passive targeting and active targeting can improve the efficacy of chemotherapy drugs significantly, reduce the mortality rate of cancer patients, and improve the quality of life of patients. In recent years, there has been extensive research on nanocarriers. In this review, the effects of several major parameters of nanoparticles on their physical and chemical properties are reviewed, and then the recent progress in the application of several commonly used nanoparticles is presented.
化疗仍然是主要的癌症治疗方法之一,但化疗的疗效相对较低,因此开发新的癌症治疗方法非常必要。纳米技术的逐渐成熟不仅为癌症治疗,也为许多其他应用提供了创新视角。有各种各样的纳米颗粒可供选择,根据需求选择合适的载体是关键问题。纳米颗粒的性能受许多参数影响,主要包括尺寸、形状、表面电荷和毒性。使用纳米颗粒作为载体实现被动靶向和主动靶向可以显著提高化疗药物的疗效,降低癌症患者的死亡率,并提高患者的生活质量。近年来,对纳米载体进行了广泛研究。在本综述中,回顾了纳米颗粒几个主要参数对其物理和化学性质的影响,然后介绍了几种常用纳米颗粒应用的最新进展。
Recent Pat Anticancer Drug Discov. 2014-1
Eur J Pharm Biopharm. 2015-6
Adv Cancer Res. 2018-5-18
Drug Res (Stuttg). 2016-11
Front Biosci (Schol Ed). 2010-6-1
J Drug Target. 2016
Curr Pharm Des. 2016
Nanomedicine (Lond). 2010-11
Curr Drug Deliv. 2016
Exp Hematol Oncol. 2025-5-19
ACS Pharmacol Transl Sci. 2025-1-23
Biomacromolecules. 2025-1-13
Biomed Eng Lett. 2024-6-12
Nanomaterials (Basel). 2024-6-13
Int J Nanomedicine. 2024
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024
Mol Ther Nucleic Acids. 2017-6-16
Proc Natl Acad Sci U S A. 2017-6-12
Cancer Chemother Pharmacol. 2017-8